ANTH — Anthera Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Anthera Pharmaceuticals reports 2015 Q1 update
Brief: Anthera Pharmaceuticals qtrly loss per share $0.28
Brief: Anthera Pharmaceuticals prices offering of 5.6 mln common shares at $4.50/shr
Brief: Anthera Pharmaceuticals announces proposed public offering of common stock
Brief: Anthera Pharmaceuticals completes interim analysis from phase 3 trial with blisibimod
Brief: Anthera Pharmaceuticals reports qtrly loss of $0.32
Brief: Anthera Pharmaceuticals entered purchase agreement with Lincoln Park Capital Fund LLC
U.S. STOCKS ON THE MOVE-Coca-Cola, Randgold Resources, Qualcomm
Brief: Anthera Pharmaceuticals completes interim analysis from trial with Blisibimod
Brief: Anthera Pharmaceuticals signs agreements with zenyaku kogyo, Amgen
Brief: Anthera Pharmaceuticals terminates loan and security agreement with Square 1 Bank
Brief: Anthera Pharmaceuticals licenses Japan rights for Blisibimod to Zenyaku Kogyo co ltd
Brief: Anthera signs manufacturing agreement with Patheon
Brief: Anthera Pharmaceuticals Q3 loss per share $0.31
Brief: Anthera Pharmaceuticals - on October 17, terminated credit and security agreement entered into on April 3, 2013 with midcap financial sbic, lp
U.S. Stocks on the Move-Rockwood, La Jolla, Michael Kors
Market Pulse: Campbell Soup, LightInTheBox, Cardiome Pharma, Radcom